Literature DB >> 486430

Phospholipid-binding properties of bovine factor V and factor Va.

J W Bloom, M E Nesheim, K G Mann.   

Abstract

Factor V and factor Va binding to single bilayer phospholipid vesicles was investigated by light-scattering intensity measurements. This technique allows the measurement of free and phospholipid-bound protein concentrations from which equilibrium constants can be obtained. As controls, the Ca2+-dependent phospholipid binding of prothrombin and factor X were also studied. The average values obtained for the dissociation constants (Kd) and lipid to protein ratio at saturation, moles/mole (n), for prothrombin (Kd = 2.3 X 10(-6) M, n = 104) and factor X (Kd = 2.5 X 10(-6) M, n = 46) binding to vesicles containing 25% Folch fraction III and 75% phosphatidylcholine in the presence of 2 mM Ca2+ were in agreement with those reported in the literature. The average factor V and factor Va values for the dissociation constants and lipid to protein ratio at saturation (moles/mole) were Kd = 7.2 X 10(-8) M and n = 270 for factor V and Kd = 4.4 X 10(-7) M and n = 76 for factor Va. In contrast to prothrombin and factor X, factor V and factor Va demonstrated Ca2+-independent lipid binding. In addition, the number of factor V and factor Va molecules bound per vesicle was found to be dependent both on the phosphatidylserine content of the vesicle and the ionic strength of the buffer.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 486430     DOI: 10.1021/bi00587a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  The Prothrombinase Complex: Assembly and Function.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Membrane binding events in the initiation and propagation phases of tissue factor-initiated zymogen activation under flow.

Authors:  Laura M Haynes; Yves C Dubief; Kenneth G Mann
Journal:  J Biol Chem       Date:  2011-12-20       Impact factor: 5.157

3.  Assembly of the prothrombinase complex.

Authors:  K G Mann; M E Nesheim; P B Tracy; L S Hibbard; J W Bloom
Journal:  Biophys J       Date:  1982-01       Impact factor: 4.033

4.  Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin.

Authors:  W H Kane; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Roles of factor Va heavy and light chains in protein and lipid rearrangements associated with the formation of a bovine factor Va-membrane complex.

Authors:  V Koppaka; W F Talbot; X Zhai; B R Lentz
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

6.  Down regulation of prothrombinase by activated protein C during prothrombin activation.

Authors:  Paul Y Kim; Michael E Nesheim
Journal:  Thromb Haemost       Date:  2010-04-13       Impact factor: 5.249

7.  Insights into the complex association of bovine factor Va with acidic-lipid-containing synthetic membranes.

Authors:  G A Cutsforth; V Koppaka; S Krishnaswamy; J R Wu; K G Mann; B R Lentz
Journal:  Biophys J       Date:  1996-06       Impact factor: 4.033

8.  Prothrombinase complex assembly on the platelet surface is mediated through the 74,000-dalton component of factor Va.

Authors:  P B Tracy; K G Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

9.  Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?

Authors:  Brian Dale; John W Eikelboom; Jeffrey I Weitz; Ed Young; Jeremy S Paikin; Michiel Coppens; Richard P Whitlock; Stuart J Connolly; Jeffrey S Ginsberg; Jack Hirsh
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

10.  Activated thrombin-activatable fibrinolysis inhibitor is generated in vivo at levels that can substantially affect fibrinolysis in chimpanzees in response to thrombin generation.

Authors:  P Y G Kim; P Y Kim; H Hoogendorn; A R Giles; M E Nesheim
Journal:  J Thromb Haemost       Date:  2008-07-04       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.